Suffer from Rheumatoid Arthritis? Here’s a Simple Way to Make Up to $625

clinical trial
Some of the links in this post are from our sponsors. We provide you with accurate, reliable information. Learn more about how we make money and select our advertising partners.

(Editor’s Note: This clinical trial is no longer open.)

Rheumatoid Arthritis is a widely feared chronic disease — and with good reason.

The most common type of autoimmune arthritis, the pain you endure is triggered by your own faulty immune system.

Detection, treatment and outlooks have greatly improved in recent years. But anyone living with the debilitating disease knows there’s a long way to go.

arthritis rain cat
Photo Source: Janessa Osborn via Pinterest

You wake from restless sleep each morning, unsure whether you’ll be in good enough shape to attack your to-do list.

It’s a neverending pain in the neck… or, more literally, in the hands, wrists and fingers.

arthritis meds y
Photo Source: via Pinterest

You Can Help Advance Arthritis Research

If you have rheumatoid arthritis in the knee or hip and are otherwise healthy, you may qualify for studies offering compensation up to $625 depending on the number of study visits (learn more here).

These studies help doctors discover better ways to treat — and hopefully eliminate — arthritis.

Plus, you could receive study medication and study-related care at no cost to you.

The study is open to men and women ages 18 or older who have been diagnosed with rheumatoid arthritis, currently experiencing swollen and tender joints. You also must be currently taking medication to treat RA symptoms and otherwise healthy.

Click here and submit your information to check your eligibility for this clinical trial. If you qualify, you’ll be able to pick from a list of research facilities in your area.

Note: Patients must currently be on a medication called Methotrexate

And if you change your mind, there’s no obligation to participate.


Dana Sitar (@danasitar) is a staff writer at The Penny Hoarder. She’s written for Huffington Post,, Writer’s Digest and more, attempting humor wherever it’s allowed (and sometimes where it’s not).